Tech Center 1700 • Art Units: 1641 1674 1677 1678 1758
This examiner grants 33% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18334135 | TRANS-INTERFACIAL MAGNETIC SEPARATION | Non-Final OA | Northwestern University |
| 18004402 | SINGLE-MOLECULE, REAL-TIME, LABEL-FREE DYNAMIC BIOSENSING WITH NANOSCALE MAGNETIC FIELD SENSORS | Non-Final OA | Western Digital Technologies, Inc. |
| 18455470 | FOLIC ACID FUNCTIONALIZED COPPER SULFIDE NANOPARTICLES FOR THE DETECTION OF OVARIAN CANCER CELLS IN FLOW | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 16971228 | LIQUID BIOPSY METHOD AND DEVICE | Final Rejection | THE JOHNS HOPKINS UNIVERSITY |
| 18300689 | ELECTROCHEMILUMINESCENCE METHOD OF DETECTING AN ANALYTE IN A LIQUID SAMPLE AND ANALYSIS SYSTEM | Non-Final OA | Hitachi High-Tech Corporation |
| 16625282 | QUANTIFICATION, ISOLATION, AND CHARACTERIZATION OF EXOSOMES USING DROPLET-BASED AND WELL-BASED MICROFLUIDIC SYSTEMS | Non-Final OA | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY |
| 17786482 | AN ACCURATE AND COMPREHENSIVE CARDIAC TROPONIN I ASSAY ENABLED BY NANOTECHNOLOGY AND PROTEOMICS | Final Rejection | Wisconsin Alumni Research Foundation |
| 18473600 | ASSAYS AND METHODS FOR THE DIAGNOSIS OF POST-STREPTOCOCCAL DISORDERS | Non-Final OA | Quest Diagnostics Investments LLC |
| 17891458 | IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING | Non-Final OA | Roche Diagnostics Operations, Inc. |
| 17162140 | Use of Biomarkers in the Assessment of the Early Transition from Arterial Hypertension to Heart Failure | Non-Final OA | Roche Diagnostics Operations, Inc. |
| 17923148 | METHOD OF USING EXTRACELLULAR VESICLES TO DETECT COMPLEMENT ACTIVATION, AND USES THEREOF TO ASSESS AND/OR MONITOR TREATMENT OF A COMPLEMENT-MEDIATED DISEASE | Non-Final OA | Alexion Pharmaceuticals, Inc. |
| 18145873 | SYSTEMS AND METHODS FOR DETECTION OF LAMININ BETA-1 SUBUNIT WITHIN TISSUE | Final Rejection | Axogen Corporation |
| 18015317 | ANTI-HUMAN IMMUNODEFICIENCY VIRUS-1 ANTIBODIES AND METHODS FOR USES THEREOF | Final Rejection | GRIFOLS DIAGNOSTIC SOLUTIONS INC |
| 17757700 | SENSOR FOR DETECTING A BIOANALYTE AND A METHOD FOR THE DETECTION THEREOF | Non-Final OA | Royal Melbourne Institute of Technology |
| 14663560 | BIOASSAY SYSTEM AND METHOD FOR DETECTING ANALYTES IN BODY FLUIDS | Final Rejection | INSTRUMENTATION LABORATORY COMPANY |
| 18012111 | Single Molecule Assays for Ultrasensitive Detection of Biomolecules | Non-Final OA | The Brigham and Women`s Hospital, Inc. |
| 18312915 | DETECTION AND QUANTIFICATION OF NATALIZUMAB | Non-Final OA | Abreos Biosciences, Inc. |
| 18032128 | SYSTEMS, COMPOSITIONS AND METHODS OF DETERMINING VIABILITY OF EMBRYOS USING THE SAME | Non-Final OA | BioIncept, LLC |
| 18025867 | DUAL-AFFINITY PROBES FOR ANALYTE DETECTION | Non-Final OA | Gemina Laboratories Ltd. |
| 18022994 | ULTRA-SENSITIVE DIGITAL RAPID CHROMATOGRAPHIC ASSAY SYSTEM AND METHOD FOR ANALYTES DETECTION | Non-Final OA | SHANGHAI SKIN DISEASE HOSPITAL |
| 18040559 | MULTIPLEXED ANALYTE DETECTION | Non-Final OA | VITAL BIOSCIENCES INC. |
| 17955765 | METHOD FOR PREDICTING THE RISK OF GETTING CANCER OR DIAGNOSING CANCER IN A FEMALE SUBJECT | Non-Final OA | SPHINGOTEC GMBH |
| 17936020 | METHODS FOR PROCESSING AND ANALYZING EXTRACELLULAR VESICLES | Final Rejection | Exosomics SpA |
| 17910526 | METHOD FOR DETECTING AND QUANTIFYING BETA-1,6-BRANCHED BETA-1,3-GLUCAN OR BETA-1,3-GLUCAN, AND KIT FOR DETECTING AND QUANTIFYING THE SAME | Final Rejection | TOEI SHINYAKU CO., LTD. |
| 17776068 | BEAD SYSTEMS, METHODS, AND APPARATUS FOR MAGNETIC BEAD-BASED ANALYTE DETECTION | Final Rejection | Quantum Diamond Technologies Inc. |
| 17437256 | Point of Care Concentration Analyzer | Non-Final OA | Novilux LLC |
| 17051278 | METHODS AND COMPOSITIONS FOR POINT OF CARE MEASUREMENT OF THE BIOAVAILABILITY OF THERAPEUTIC BIOLOGICS | Non-Final OA | GENALYTE, INC. |
| 16970136 | METHOD FOR OBTAINING A SPERMATOZOID CELL POPULATION WITH IMPROVED FITNESS | Non-Final OA | UNIVERSIDAD DEL PAIS VASCO/EUSKAL HERRIKO UNIBERTSITATEA |
| 16968473 | METHOD FOR THE QUANTIFICATION OF THE TOTAL GLUTEN CONTENT OF GRAINS IN FOOD SAMPLES | Final Rejection | R-Biopharm AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy